<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">primary-cell-atlas</item><item key="factor_count">None</item><item key="sample_count">745</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>carcinoma</item><item>invasive ductal carcinoma</item><item>lymph</item><item>protein</item></item><item key="species">human</item><item key="is_default">True</item><item key="geo_gse_id">BDS_00013</item><item key="id">2430</item><item key="name">Primary Cell Atlas</item></item><item><item key="slug">gene-expression-profiles-of-breast-cancer-subtypes</item><item key="factor_count">4</item><item key="sample_count">30</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>estrogen</item><item>external</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21947</item><item key="id">1332</item><item key="name">Gene expression profiles of breast cancer subtypes are detectable in histologically normal breast epithelium</item></item><item><item key="slug">gene-transcription-signature-of-obesity-in-breast</item><item key="factor_count">10</item><item key="sample_count">103</item><item key="tags"><item>adipocyte</item><item>body</item><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>disease</item><item>insulin</item><item>obesity</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-24185</item><item key="id">1291</item><item key="name">Gene transcription signature of obesity in breast cancer</item></item><item><item key="slug">glutamine-sensitivity-analysis-identifies-the-xct</item><item key="factor_count">3</item><item key="sample_count">26</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>disease</item><item>epithelial cell</item><item>glutamine</item><item>stromal cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-48984</item><item key="id">1209</item><item key="name">Glutamine sensitivity analysis identifies the xCT antiporter as a common triple negative breast tumor therapeutic target.</item></item><item><item key="slug">her2-enriched-tumor-initiating-cell-htic-genomic-p</item><item key="factor_count">5</item><item key="sample_count">50</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37946</item><item key="id">1245</item><item key="name">HER2-enriched tumor initiating cell (HTIC) genomic predictor of response following neoadjuvant trastuzumab-based chemotherapy in HER2+ breast cancer</item></item><item><item key="slug">letrozole-femara-early-and-late-responses-to-treat</item><item key="factor_count">1</item><item key="sample_count">176</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-20181</item><item key="id">1348</item><item key="name">Letrozole (Femara) early and late responses to treatment</item></item><item><item key="slug">multi-level-support-vector-regression-analysis-to</item><item key="factor_count">0</item><item key="sample_count">6</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>estrogen</item><item>line</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-20700</item><item key="id">1369</item><item key="name">Multi-level Support Vector Regression analysis to identify condition-specific regulatory networks</item></item><item><item key="slug">novel-roles-fro-erk5-and-cofiin-as-critical-mediat</item><item key="factor_count">0</item><item key="sample_count">8</item><item key="tags"><item>actin</item><item>adenocarcinoma</item><item>breast</item><item>breast adenocarcinoma</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>estrogen</item><item>genome</item><item>hormone</item><item>membrane</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-53394</item><item key="id">1196</item><item key="name">Novel Roles fro ERK5 and Cofiin as Critical Mediators Linking Estrogen Receptor &#945;-Driven Transcription, Actin Reorganization and Invasiveness in Breast cancer</item></item><item><item key="slug">paclitaxel-resistant-mda-mb-231-cells-and-resensit</item><item key="factor_count">0</item><item key="sample_count">16</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-12791</item><item key="id">1290</item><item key="name">Paclitaxel resistant MDA-MB-231 Cells and resensitization with bexarotene treatment</item></item><item><item key="slug">response-prediction-to-neoadjuvant-chemotherapy</item><item key="factor_count">2</item><item key="sample_count">22</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-29561</item><item key="id">1237</item><item key="name">Response prediction to neoadjuvant chemotherapy</item></item></data></biogps>
